Arca
Skip to content
Tools
Tools

ATP4A, ATP4B: Potassium-transporting ATPase

Complex in Homo sapiens that 10 drugs act on.

  • Drugs that act on it: 10
  • Approved: 7
  • In phases 1 to 3: 3
  • Sponsors: 9

Who is on it, and how far along

Every drug ChEMBL records acting on ATP4A, by the furthest stage it has reached for any use, coloured by modality.

How to read this

Each mark is one drug. Columns run from approved to phase 1; hover or tap a mark for its sponsor, modality and open trials, and click it to open the drug.

  • Small molecule 10

Approved7

  • Omeprazole
  • Esomeprazole
  • Vonoprazan
  • Dexlansoprazole
  • Lansoprazole
  • Pantoprazole
  • Rabeprazole

Phase 33

  • Tegoprazan
  • Abeprazan
  • Ilaprazole

Phase 20

    Phase 10

      Sponsors

      Drugs on this target per company: the US application holder, else the industry sponsor leading the most of its trials.

      The landscape

      Every drug acting on it, furthest along first. The sponsor is the US application holder where there is one, else the industry lead sponsor of most of its registered trials. 9 of 10 act as: Potassium-transporting ATPase inhibitor; the rest name their own mechanism.
      OmeprazoleApprovedEli LillySmall moleculeInhibitor94
      EsomeprazoleApprovedAnabio R&DSmall moleculeInhibitor53
      VonoprazanApprovedPhathom PharmaceuticalsSmall moleculeInhibitor50
      DexlansoprazoleApprovedTakeda Pharmaceuticals USASmall moleculeInhibitor28
      LansoprazoleApprovedTakeda Pharmaceuticals USASmall moleculeInhibitor28
      PantoprazoleApprovedPfizerSmall moleculeInhibitor28
      RabeprazoleApprovedWaylis TherapeuticsSmall moleculeInhibitor21
      TegoprazanPhase 3HK inno.N CorporationSmall moleculeBlockerPotassium-transporting ATPase blocker20
      AbeprazanPhase 3Daewoong PharmaceuticalSmall moleculeInhibitor8
      IlaprazolePhase 3Il-Yang Pharm. Co., Ltd.Small moleculeInhibitor2

      Open trials

      The most recently posted recruiting or ongoing trials naming each drug (up to 8 a drug), 56 in all, from ClinicalTrials.gov.
      Safety of Vonoprazan-Amoxicillin Dual Therapy Versus Concomitant Quadruple Therapy for H. Pylori EradicationVonoprazan, OmeprazolePhase 4RecruitingIgnacio MoratorioNov 9, 2026
      An Open-label, DDI Study to Investigate the Effects of Duvakitug on the PK of Selected Cytochrome P450 SubstratesOmeprazolePhase 1Not yet recruitingSanofiNov 6, 2026
      Efficacy and Safety of K-CAB(Tegoprazan) 25 mg as Maintenance Therapy Following the Treatment of GERDTegoprazan—RecruitingHK inno.N CorporationNov 6, 2026
      A Study of Imlunestrant (LY3484356) in Healthy Female ParticipantsOmeprazolePhase 1Not yet recruitingEli Lilly and CompanyNov 5, 2026
      Prophylactic PPI Use After EUS-GE ProcedureEsomeprazole, OmeprazoleNot applicableNot yet recruitingChanghai HospitalOct 27, 2026
      Efficacy and Safety of Linarazen Gluconate Capsules Combined With Amoxicillin (Dual-Drug Therapy) Versus Bismuth-Containing Quadruple Therapy for First-Line Eradication of Helicobacter Pylori InfectionEsomeprazolePhase 4RecruitingYongquan ShiOct 27, 2026
      Assessing the Effect of a Proton Pump Inhibitor on the Pharmacokinetics of DZD8586 in Healthy Participants (TAI-SHAN21)RabeprazolePhase 1RecruitingDizal PharmaceuticalsOct 22, 2026
      A Study of LY3873862 in Participants With Sporadic or Familial Amyotrophic Lateral Sclerosis (ALS).OmeprazolePhase 1Not yet recruitingEli Lilly and CompanyOct 20, 2026
      A Multiple-dose Study Investigating the Drug-drug Interaction Potential and QTc Effects of Fosmanogepix in Healthy Adult SubjectsOmeprazolePhase 1RecruitingBasilea PharmaceuticaOct 19, 2026
      Efficacy and Safety of JP-1366-based Triple Therapy in Helicobacter Pylori-positive SubjectsDexlansoprazole, LansoprazolePhase 3Not yet recruitingOnconic Therapeutics Inc.Oct 15, 2026
      A Phase I Study of the Interaction of D-2570 With Other Drugs in Healthy AdultsOmeprazolePhase 1Not yet recruitingInventisBio Co., LtdOct 15, 2026
      A Study to Investigate the Effect of Omeprazole and Cyclosporine on Velzatinib in Healthy ParticipantsOmeprazolePhase 1Not yet recruitingGlaxoSmithKlineOct 7, 2026
      Vonoprazan-Amoxicillin Dual Therapy for Helicobacter Pylori Infection in United States AdolescentsVonoprazanPhase 2Not yet recruitingBoston Children's HospitalOct 6, 2026
      Efficacy and Safety of Second-Line Helicobacter Pylori EradicationEsomeprazole, TegoprazanNot applicableActive, not recruitingSeoul National University Bundang HospitalOct 2, 2026
      Tegoprazan-Aspirin Drug Interaction in Healthy Adult Male VolunteersTegoprazanPhase 1Not yet recruitingHK inno.N CorporationOct 1, 2026
      PPI Dosing Per CYP2C19 GenotypePantoprazolePhase 4RecruitingUniversity of FloridaSep 28, 2026
      Bacillus Probiotics With Bismuth Quadruple Therapy for Helicobacter Pylori InfectionEsomeprazoleNot applicableNot yet recruitingAnabio R&DSep 18, 2026
      A Study to Evaluate Tegoprazan as a Diagnostic Tool for GERDTegoprazanPhase 4Not yet recruitingHK inno.N CorporationSep 17, 2026
      A Study of Navlimetostat (BMS-986504) Drug Interactions and Food Effect in Healthy ParticipantsPantoprazolePhase 1RecruitingBristol-Myers SquibbSep 2, 2026
      A Study of RO7890597 in Healthy Adult VolunteersRabeprazolePhase 1RecruitingGenentech, Inc.Sep 1, 2026
      GMPA Versus PPI for Gastric Protection and aGVHD RiskEsomeprazoleNot applicableRecruitingFirst Affiliated Hospital of Zhejiang UniversityAug 28, 2026
      Mirgeal® Gel as Add-on Therapy to Esomeprazole in Adults With Non-Erosive Gastroesophageal Reflux DiseaseEsomeprazoleNot applicableNot yet recruitingLiaquat University of Medical & Health SciencesAug 27, 2026
      Efficacy And Safety of Bismuth-Tetracycline-Rabeprazole Triple For First-Line Eradication of Helicobacter Pylori InfectionRabeprazoleNot applicableNot yet recruitingChih-An Shih, MDAug 26, 2026
      Keverprazan vs Pantoprazole for the Treatment of ANVUGIBPantoprazoleNot applicableNot yet recruitingGeneral Hospital of Shenyang Military RegionAug 20, 2026
      Potassium-competitive Acid Blocker Versus Double Dose Proton Pump Inhibitors in High High-risk Peptic Ulcer BleedingEsomeprazoleNot applicableNot yet recruitingNational Cheng-Kung University HospitalAug 19, 2026
      Efficacy and Safety of 14-Day Vonoprazan-Minocycline Dual Therapy for Helicobacter Pylori EradicationVonoprazanPhase 4Not yet recruitingQilu Hospital of Shandong UniversityAug 11, 2026
      A Study to Evaluate the Efficacy and Safety of Vonoprazan 10 mg Compared to Placebo for Relief of Episodic Heartburn in Participants With Symptomatic Non-Erosive Gastroesophageal Reflux Disease Through 24 WeeksVonoprazanPhase 3RecruitingPhathom Pharmaceuticals, Inc.Aug 7, 2026
      Assessing the Role of Proton Pump Inhibitors in Reducing Aspiration Incidence in Pediatric Laryngomalacia CasesEsomeprazoleNot applicableRecruitingMinia UniversityAug 6, 2026
      Efficacy and Safety of DWP14012 for Long-Term Maintenance Therapy in Patients With Healed Erosive EsophagitisAbeprazanPhase 3Not yet recruitingDaewoong Pharmaceutical Co. LTD.Aug 5, 2026
      Olanzapine Based Dexamethasone-sparing Regimen for Breast Cancer Patients With Metabolic-risk FactorsPantoprazoleNot applicableRecruitingAlexandria UniversityAug 4, 2026
      Phase 3 to Evaluate the Efficacy and Safety of DWP14012 in Patients With Gastric UlcerDexlansoprazole, Lansoprazole, AbeprazanPhase 3Not yet recruitingDaewoong Pharmaceutical Co. LTD.Jul 28, 2026
      Phase 3 Study of JP-1366: Efficacy and Safety of JP-1366 as Maintenance Therapy in Subjects With Healed Erosive EsophagitisDexlansoprazole, LansoprazolePhase 3Not yet recruitingOnconic Therapeutics Inc.Jul 28, 2026
      Vonoprazan Alone vs With Itopride for Functional Dyspepsia: The VIVA TrialVonoprazanNot applicableRecruitingAsian Institute of Gastroenterology, IndiaJul 28, 2026
      Efficacy Comparison of 10-Day High-Dose Versus 14-Day Standard-Dose Vonoprazan Plus Amoxicillin in Helicobacter Pylori Eradication: A Multicenter Non-Inferiority Randomized Controlled TrialVonoprazanPhase 4Not yet recruitingShandong UniversityJul 22, 2026
      A Study of Compare the Pharmacokinetic, Pharmacodynamic and Safety/Tolerability Characteristics Following Multiple Oral Administration of AD-234, AD-2341, and AD-2342 in Healthy AdultsVonoprazan, AbeprazanPhase 1Not yet recruitingAddpharma Inc.Jul 21, 2026
      Tegoprazan Versus Lansoprazole for Endoscopic Ulcer Healing in Bleeding Peptic UlcersDexlansoprazole, Lansoprazole, TegoprazanPhase 2RecruitingUniversitas IndonesiaJul 16, 2026
      Potassium Competitive Acid Blocker (PCAB) Test-Guided vs Physiologic Test-Guided Treatment in Patients With Typical Reflux SymptomsVonoprazanNot applicableEnrolling by invitationMahidol UniversityJul 16, 2026
      Tegoprazan for Prevention of Gastrointestinal Complication in Ischemic Stroke Patients on Antiplatelet Therapy (TegoStroke)TegoprazanPhase 3RecruitingHanyang University Guri HospitalJul 7, 2026
      A Study to Compare How CHF10196 (Florensocatib) is Absorbed Into the Blood When Given Alone and With a Drug That Reduces Stomach Acid in Healthy Male ParticipantsPantoprazolePhase 1Not yet recruitingChiesi Farmaceutici S.p.A.Jul 6, 2026
      An Observational Study to Evaluate the Efficacy and Safety of K-CAB Tab./K-CAB ODT(Tegoprazan) in GERD PatientsTegoprazan—RecruitingHK inno.N CorporationJul 1, 2026
      Comparative Effectiveness of Alginate, Magaldrate, Sucralfate, Proton Pump Inhibitors, and Diet in Laryngopharyngeal Reflux DiseaseDexlansoprazole, Lansoprazole, Pantoprazole, RabeprazolePhase 4Not yet recruitingUniversity of MonsMay 28, 2026
      Study to Evaluate the Effect of Rabeprazole Sodium Enteric-coated Tablets on the Pharmacokinetics of TQ05105 TabletsRabeprazolePhase 1Active, not recruitingChia Tai Tianqing Pharmaceutical Group Co., Ltd.May 27, 2026
      Comparison of Rabeprazole and Vonoprazan in the Prevention of Post-endoscopic Variceal Ligation Ulcer in Patients With CirrhosisRabeprazolePhase 3Not yet recruitingKing George's Medical UniversityMay 27, 2026
      Levofloxacin-Based Sequential Therapy Versus Bismuth Quadruple Therapy for Helicobacter Pylori EradicationDexlansoprazole, LansoprazoleNot applicableNot yet recruitingUniversity of Health Sciences LahoreMay 8, 2026
      Fexuclue for Prevention of NSAIDs-Induced Peptic Ulcer in Real-World PracticeAbeprazan—Not yet recruitingDaewoong Pharmaceutical Co. LTD.Apr 30, 2026
      Paracetamol and Ibuprofen With or Without Famotidine for Calcific Tendinitis of the ShoulderPantoprazoleNot applicableNot yet recruitingUniversity Hospital DubravaApr 20, 2026
      Study to Evaluate the Efficacy and Safety of Fexuprazan in Prevention of NSAIDs Induced Peptic UlcerDexlansoprazole, Lansoprazole, AbeprazanPhase 4Not yet recruitingDaewoong Pharmaceutical Co. LTD.Apr 16, 2026
      FENOX Trial (Comparative Effectiveness of Fexuprazan Co-therapy in Patients Receiving Non-Vitamin K Antagonist Oral Anticoagulants)AbeprazanNot applicableNot yet recruitingEwha Womans University Mokdong HospitalMar 27, 2026
      Fexuprazan for Prevention of Upper Gastrointestinal Bleeding in High Bleeding Risk Patients Receiving Dual Antiplatelet TherapyDexlansoprazole, Lansoprazole, AbeprazanNot applicableRecruitingSUK MIN SEOMar 18, 2026
      Effect of ZaStaprazan on Platelet Reactivity of Clopidogrel After PercuTaneous CoronAry InteRventionRabeprazolePhase 4RecruitingYonsei UniversityMar 13, 2026
      Fecal Molecular Susceptibility-guided Hp Rescue TherapyTegoprazanPhase 4Not yet recruitingShanghai Zhongshan HospitalFeb 12, 2026
      Efficacies of Bismuth-amoxicillin-vonoprazan Triple Therapy and Bismuth Quadruple TherapyRabeprazoleNot applicableRecruitingKaohsiung Medical UniversityJan 22, 2026
      Vonoprazan vs Proton Pump Inhibitor With Vitamin D or Probiotics Based Triple Therapy for Eradication of Helicobacter Pylori InfectionPantoprazolePhase 2RecruitingTanta UniversityDec 19, 2025
      Efficacy and Safety of FEXUCLUE Tab. In Patients With Acute or Chronic GastritisAbeprazan—RecruitingDaewoong Pharmaceutical Co. LTD.Apr 29, 2025
      Study to Evaluate the Efficacy and Safety of Ilaprazole 10 mg in Prevention NSAIDs Associated Peptic UlcerIlaprazolePhase 3Active, not recruitingIl-Yang Pharm. Co., Ltd.Feb 29, 2024
      Efficacy of Proton Pump Inhibitors in Cirrhotic Patients With Acute Variceal BleedingIlaprazolePhase 4Not yet recruitingWest China HospitalNov 22, 2022

      Drugs, mechanisms, furthest stage (max phase) and modality (molecule type) are from ChEMBL CHEMBL2095173, ChEMBL 37, fetched 2026-11-18 (CC BY-SA 3.0). Sponsors are the US application holder (Drugs@FDA) for approved drugs with a US page, else the industry lead sponsor of the most of the drug's ClinicalTrials.gov trials. Open trials are recruiting or ongoing studies naming the drug as an intervention on ClinicalTrials.gov, checked daily; this page as of 2026-11-21. ChEMBL and Open Targets

      Esc

      Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

      Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.